| Literature DB >> 27467147 |
Wenqiao Hui1,2, Song Jiang2, Xianxia Liu2, Qian Ban2,3, Sheng Chen1, Bin Jia2.
Abstract
BACKGROUND: Cystic Echinococcosis (CE), caused by infection with the Echinococcus granulosus (E. granulosus), represents considerable health problems in both humans and livestock. Nevertheless, the genetic program that regulates the host response to E. granulosus infection is largely unknown. Previously, using microarray analysis, we found that the innate immunity played a vital role in the E. granulosus defense of the intestine tissue where E. granulosus first invaded. Subsequently, we turned our attention to investigating the molecular immune mechanism in its organ target, the liver, which is where the E. granulosus metacestodes are established and live for very long periods. In this work, the microarray-based methodology was used to study gene expression profiles in the liver of sheep infected with E. granulosus at 8 weeks post infection, corresponding to the early cystic established phase.Entities:
Mesh:
Year: 2016 PMID: 27467147 PMCID: PMC4965101 DOI: 10.1371/journal.pone.0160000
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primer sequence for qRT-PCR analysis of gene transcripts.
| Gene | Primer sequences (5’-3’) | Annealing temperature(°C) | Expected size (bp) |
|---|---|---|---|
| GAPDH | F:CTGACCTGCCGCCTGGAGAAA | 59.0 | 149 |
| R: GTAGAAGAGTGAGTGTCGCTGTT | |||
| NDUFA1 | F: AAGGGACCTGGAAGGGAGT | 57.0 | 176 |
| R: CTGATATGAATAATGGGCAACC | |||
| APOA4 | F: GAGCCGAGGCGGAGGTCAAT | 64.0 | 237 |
| R: CGGAGTCCTTAGTCAGCCGTTCAT | |||
| CⅡTA | F: CAAAGCATGACCGCTGGAAATT | 57.0 | 209 |
| R: AAACAAACAGGAAATGGAGGCAAA | |||
| SLC7A11 | F: ACCCTTTGACAATGATAATGC | 54.0 | 111 |
| R: GATAAATCAGCCCAGCAACT | |||
| C6 | F: CAACATCCAGCCATCACTT | 54.0 | 245 |
| R: GGAGGGTAACAGGCAGACAC | |||
| PI4K2B | F: GAAGAGGGTCCGCAGTTA | 52.0 | 185 |
| R: TTGACGCAGAAGAGTTGG |
Partial differential expression genes in the liver, organized according to their function groups.
| Gene | Accession number | Gene ID | Description | FC |
|---|---|---|---|---|
| NDUFA1 | NM_001318974.1 | 974987257 | NADH dehydrogenase 1 | 62.2 |
| SOD1 | NM_001145185.1 | 223633903 | superoxide dismutase 1, soluble | 2.67 |
| AACS | XM_012097667.2 | 965982956 | acetoacetyl-CoA synthetase | 17.4 |
| P450RAI-2 | NM_007811.2 | 178057350 | cytochrome P450 retinoid metabolizing protein | 16.2 |
| MRPL39 | XM_004002812.3 | 965916887 | mitochondrial ribsomal protein L39, nuclear gene encoding mitochondrial protein | 7.54 |
| MCM | XM_004014349.3 | 965967846 | methylmalonyl CoA mutase | 80.8 |
| DARS | NM_001161887.1 | 240849240 | aspartyl-tRNAsynthetase | 12.6 |
| SCD | NM_001009254.1 | 57164288 | stearoyl-CoA desaturase (delta-9-desaturase) | 35.8 |
| FASN | XM_015098375.1 | 965957117 | fatty acid synthase | 16.3 |
| THRSP | XM_004019431.3 | 965995379 | thyroid hormone responsive | 19.9 |
| HMGCS1 | XM_015101308.1 | 965980758 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | 14.3 |
| SQLE | NM_001104929.1 | 157278599 | squaleneepoxidase | 12.1 |
| FDPS | XM_004002589.2 | 802989579 | farnesyldiphosphate synthase | 16.5 |
| SCAP | XM_015102452.1 | 965990456 | SREBF chaperone | -14.6 |
| PLA2G2A | XM_012153325.2 | 965923174 | phospholipase A2, group IIA | -61.7 |
| APOA1 | XM_012095497.1 | 803156056 | apolipoprotein A-I | -2.9 |
| APOA4 | XM_004016047.3 | 965976075 | apolipoprotein A-IV | -29.8 |
| CES8 | BC166638.1 | 187252608 | carboxylesterase 8 | -35.4 |
| HBB | NM_001097648.1 | 164448673 | hemoglobin-beta | 37.0 |
| HBG | AH001245.1 | 165904 | hemoglobin-gamma | 47.9 |
| HP | NM_001040470.2 | 402743675 | Haptoglobin | -41.0 |
| ACE2 | XM_012106267.2 | 966008903 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 10.4 |
| Mllt1 | XM_015095867.1 | 965936538 | myeloid/lymphoid or mixed-lineage leukemia 1 | 14.0 |
| HIG2 | GAAI01005551.1 | 509131589 | hypoxia-inducible protein 2 | -9.6 |
| THBS4 | XM_015096703.1 | 965943888 | thrombospondin 4 | -14.4 |
| BLVRA | XM_004007991.2 | 803063619 | biliverdinreductase A。 | -10.7 |
| SNTB1 | XM_015097677.1 | 965952304 | Basic beta 1 syntrophin-like | 25.2 |
| Gabrb2 | JQ911755.1 | 387158479 | Gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 | 12.1 |
| Pou2af1 | XM_004016007.3 | 965976872 | POU class 2 associating factor 1 | 13.5 |
| SLC7A11 | NM_001252182.1 | 356582217 | solute carrier family 7, member 11 | 24.4 |
| SLC1A2 | XM_012096232.2 | 965978842 | solute carrier family 1, member 2 | 228.6 |
| CACNB3 | XM_012174365.2 | 965926784 | calcium channel, voltage-dependent, beta 3 subunit | -2.8 |
| SLC16A6 | XM_015098988.1 | 965962049 | solute carrier family 16, member 6 | -19.6 |
| SLC13A5 | XM_004012581.3 | 965958686 | solute carrier family 13, member 5 | -12.5 |
| C6 | XM_004017016.3 | 965980802 | complement component 6 | 2.9 |
| C4A | XM_012100915.1 | 803188285 | complement component 4A | 2.3 |
| CR2 | NM_001009724.1 | 57526243 | complement component (3d/Epstein Barr virus) receptor 2 (CR2) | 4.8 |
| C3 | XM_015095649.1 | 965934749 | complement component 3 | 4.5 |
| LYSB | XM_004014566.3 | 965968945 | intestinal lysozyme | -112.7 |
| LBP | NM_001135930.1 | 209693409 | Lipopolysaccharide binding protein | 2.2 |
| ULBP27 | NM_001168616.1 | 274317279 | UL16-binding protein 27 | 54.7 |
| MHC-DQA2 | Y07898.1 | 1542854 | MHC class II,DQA 2 | -2.3 |
| CD3D | NM_001009382.1 | 57164384 | CD3d molecule, delta | -2.9 |
| CD1 | Z36890.1 | 1296950 | CD1 | -3.3 |
| CD4 | NM_001129902.1 | 194018571 | CD4 | -2.6 |
| SWAP70 | XM_004016163.2 | 803156750 | SWAP switching B-cell complex 70kDa subunit | -2.1 |
| FKBP1B | XM_015094249.1 | 965924814 | FK506 binding protein 1B | -19.7 |
| CD28 | NM_001009441.1 | 57164228 | CD28 molecule | -6.9 |
| C IITA | XM_015104076.1 | 966002573 | MHC class II transactivator | -34.4 |
| AMICA1 | GAAI01003726 | 509133602 | adhesion molecule, interacts with CXADR antigen 1 | -125.8 |
| IGSF3 | XM_015092200.1 | 965915911 | immunoglobulin superfamily, member 3 | -4.3 |
| TMIGD1 | XM_004012526.3 | 965958386 | transmembrane and immunoglobulin domain containing 1 | 9.3 |
| IGSF11 | XM_015092456.1 | 965917273 | immunoglobulin superfamily, member 11 | 11.7 |
| IGSF5 | XM_004003353.3 | 965918454 | immunoglobulin superfamily, member 5 | -16.2 |
| CXCL2 | GAAI01002159 | 509135527 | chemokine (C-X-C motif) ligand 2 | 13.0 |
| CCR6 | XM_015097525.1 | 965951574 | chemokine (C-C motif) receptor 6 | -5.6 |
| CXCR6 | XM_004018516.3 | 965990585 | chemokine (C-X-C motif) receptor 6 | -2.7 |
| PI4K2B | XM_004009745.3 | 965941690 | phosphatidylinositol 4-kinase type 2 beta | 10.5 |
| FAIM2 | XM_015094686.1 | 965926736 | Fas apoptotic inhibitory molecule 2 | 65.76 |
| P21 | XM_012107531.2 | 966011943 | p21 protein (Cdc42/Rac)-activated kinase 1 | 2.22 |
Note: Table 2 shows partially differential expression genes (E. granulosus challenged at 8 wks vs. Healthy controls) with P-value<0.05 and fold change (FC)≥2, which were listed with their respective function.
Fig 1Validation of microarray data by qPCR on six randomly selected genes.
Fig 2Schematic diagram summarizing interaction linked to differential expression genes in the liver of sheep infected with CE.